Results 151 to 160 of about 42,628 (216)

Encapsulation of Polyphenolic Preparation in Gelatin Fruit Jellies Slows the Digestive Release of Cholinesterase Inhibitors In Vitro. [PDF]

Antioxidants (Basel)
Szwajgier D, Baranowska-Wójcik E, Kukula-Koch W, Krzos K.   +3 more
europepmc   +1 more source

Cholinesterase inhibitors: drugs looking for a disease?

PLoS Medicine, 2006
Marina Maggini, Nicola Vanacore, Roberto Raschetti   +2 more
doaj   +1 more source

Repurposing Alzheimer's disease medications-systemic cholinesterase inhibitors-for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration. [PDF]

Ther Adv Ophthalmol
Rajagopal S, Ahuja P, Quach V, Luong C, Raji MA.   +4 more
europepmc   +1 more source

Efficient Access to New Thienobenzo-1,2,3-Triazolium Salts as Preferred Dual Cholinesterase Inhibitors. [PDF]

Biomolecules
Mlakić M, Sviben M, Ratković A, Raspudić A, Barić D, Šagud I, Lasić Z, Odak I, Škorić I.   +8 more
europepmc   +1 more source

Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis.

JAMA Neurol, 2023
d'Angremont E, Begemann MJH, van Laar T, Sommer IEC.   +3 more
europepmc   +1 more source

Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors. [PDF]

RSC Med Chem
Bindra S, Mostafa EM, Abdelgawad MA, Selim S, Kumar S, Mathew B.   +5 more
europepmc   +1 more source

Longitudinal impact of cholinesterase inhibitors on cholinergic white matter integrity in mild cognitive impairment: A diffusion MRI study. [PDF]

J Alzheimers Dis Rep
Ramezannezhad E, Alzheimer's Disease Neuroimaging Initiative.   +1 more
europepmc   +1 more source

Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies. [PDF]

Future Med Chem
Kassem AF, Omar MA, Temirak A, El-Shiekh RA, Srour AM.   +4 more
europepmc   +1 more source

Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors. [PDF]

PLoS One
Guerguer FZ, Rossafi B, Abchir O, Raouf YS, Albalushi DB, Samadi A, Chtita S.   +6 more
europepmc   +1 more source